Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Bhowmick Neil — Kairos Pharma, LTD. insider: 2 transactions · InsiderLens

Home / Insiders / Bhowmick Neil

Bhowmick Neil

Chief Scientific Officer at Kairos Pharma, LTD. · on record since Sep 24, 2024

Insider trading activity of Bhowmick Neil

Transactions on record: 2; since Apr 7, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 30, 2025

Figures computed from official regulatory filings — methodology.

Companies where Bhowmick Neil has traded

Kairos Pharma, LTD.2 tx · Dec 30, 2025

Track record of Bhowmick Neil

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bhowmick Neil

Co-insiders of Bhowmick Neil

Bae Hyun W.Kairos Pharma, LTD.
Keyoung Hansoo MichaelKairos Pharma, LTD.
MAZANET ROSEMARYKairos Pharma, LTD.
Murali RamachandranKairos Pharma, LTD.
Samuelson DougKairos Pharma, LTD.
Singhvi RahulKairos Pharma, LTD.
Yu John SKairos Pharma, LTD.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Kairos Pharma, LTD.	Dec 30, 2025	Award	171,756	0.00 USD	$0	SEC
Kairos Pharma, LTD.	Apr 7, 2025	Award	14,000	0.00 USD	$0	SEC